| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ACAN | MMP1 | ENSMMUP00000015113 | ENSMMUP00000002724 | Aggrecan. | Matrix metallopeptidase 1. | 0.615 |
| ACAN | MMP10 | ENSMMUP00000015113 | ENSMMUP00000028662 | Aggrecan. | Matrix metallopeptidase 10. | 0.519 |
| ACAN | MMP3 | ENSMMUP00000015113 | ENSMMUP00000005671 | Aggrecan. | Matrix metallopeptidase 3. | 0.863 |
| ACAN | MMP9 | ENSMMUP00000015113 | ENSMMUP00000021747 | Aggrecan. | Uncharacterized protein. | 0.670 |
| ACAN | TIMP1 | ENSMMUP00000015113 | ENSMMUP00000041096 | Aggrecan. | Metalloproteinase inhibitor 1; Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling (By similarity). | 0.452 |
| ACAN | TIMP3 | ENSMMUP00000015113 | ENSMMUP00000067268 | Aggrecan. | Metalloproteinase inhibitor 3; Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15 (By similarity). | 0.489 |
| APOE | MMP10 | ENSMMUP00000048554 | ENSMMUP00000028662 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Matrix metallopeptidase 10. | 0.576 |
| APOE | MMP3 | ENSMMUP00000048554 | ENSMMUP00000005671 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Matrix metallopeptidase 3. | 0.801 |
| APOE | MMP9 | ENSMMUP00000048554 | ENSMMUP00000021747 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Uncharacterized protein. | 0.766 |
| MMP1 | ACAN | ENSMMUP00000002724 | ENSMMUP00000015113 | Matrix metallopeptidase 1. | Aggrecan. | 0.615 |
| MMP1 | MMP10 | ENSMMUP00000002724 | ENSMMUP00000028662 | Matrix metallopeptidase 1. | Matrix metallopeptidase 10. | 0.797 |
| MMP1 | MMP3 | ENSMMUP00000002724 | ENSMMUP00000005671 | Matrix metallopeptidase 1. | Matrix metallopeptidase 3. | 0.986 |
| MMP1 | MMP9 | ENSMMUP00000002724 | ENSMMUP00000021747 | Matrix metallopeptidase 1. | Uncharacterized protein. | 0.969 |
| MMP1 | NFKB1 | ENSMMUP00000002724 | ENSMMUP00000034946 | Matrix metallopeptidase 1. | Uncharacterized protein. | 0.938 |
| MMP1 | RELA | ENSMMUP00000002724 | ENSMMUP00000054901 | Matrix metallopeptidase 1. | RELA proto-oncogene, NF-kB subunit. | 0.919 |
| MMP1 | TIMP1 | ENSMMUP00000002724 | ENSMMUP00000041096 | Matrix metallopeptidase 1. | Metalloproteinase inhibitor 1; Metalloproteinase inhibitor that functions by forming one to one complexes with target metalloproteinases, such as collagenases, and irreversibly inactivates them by binding to their catalytic zinc cofactor. Acts on MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP10, MMP11, MMP12, MMP13 and MMP16. Does not act on MMP14. Also functions as a growth factor that regulates cell differentiation, migration and cell death and activates cellular signaling cascades via CD63 and ITGB1. Plays a role in integrin signaling (By similarity). | 0.946 |
| MMP1 | TIMP2 | ENSMMUP00000002724 | ENSMMUP00000007081 | Matrix metallopeptidase 1. | NTR domain-containing protein. | 0.867 |
| MMP1 | TIMP3 | ENSMMUP00000002724 | ENSMMUP00000067268 | Matrix metallopeptidase 1. | Metalloproteinase inhibitor 3; Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15 (By similarity). | 0.668 |
| MMP10 | ACAN | ENSMMUP00000028662 | ENSMMUP00000015113 | Matrix metallopeptidase 10. | Aggrecan. | 0.519 |
| MMP10 | APOE | ENSMMUP00000028662 | ENSMMUP00000048554 | Matrix metallopeptidase 10. | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | 0.576 |
